GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, TYR, XDH |
12.1099 |
[BP] GO:0042221 |
response to chemical
|
ADRA2A, AKR1B1, ALPL, APEX1, APP, AR, AXL, CA2, CA9, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KCNH2, KDR, MMP2, MMP9, PPARA, PTGES, RELA, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TYR |
11.5985 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, APP, AR, AXL, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESRRA, FABP3, HSD17B2, IGF1R, INSR, MMP2, MMP9, PPARA, PTGES, RELA, RORC, SLC6A4, SRC, TEK, TYR |
11.597 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD2, EGFR, ESR1, FABP3, FABP4, FDPS, FUT7, HSD11B1, HSD17B1, HSD17B2, HSD17B3, MET, PPARA, PTGES |
11.4688 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CES1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP2D6, ESR1, FDPS, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
11.4311 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, APP, AR, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESRRA, FLT3, PTGES, RELA, RORC, SLC6A4, SRC, TEK, TYR |
11.3864 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA2A, AKR1B1, APP, AR, CDC25B, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTGES, RELA, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
11.3129 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, ALPL, APEX1, APP, AR, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MMP2, PPARA, PTGES, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TYR |
11.1145 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.0102 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP2, NUAK1, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, TYR, XDH |
10.8831 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, FDPS, FUT7, GLO1, HSD17B3, HSPA1A, PIM1, PPARA, PTGES, TYR, XDH |
10.8404 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA2A, AKR1B1, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F3, FLT3, GPR35, HCAR2, HSPA1A, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
10.5689 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA2A, AKR1B1, APP, AR, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F3, FLT3, GPR35, HCAR2, HSPA1A, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
10.5399 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.1974 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, ALPL, APEX1, APP, AR, CA2, CA9, CSNK2A1, CYP1A2, DRD1, DRD5, EGFR, ESR1, ESRRA, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, RELA, SLC6A4, SMAD3, SRC, TEK |
9.63561 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRA2A, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA12, CA2, CA7, CACNA1C, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, INSR, KCNH2, KDR, MAOA, MET, PPARA, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
9.62479 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
8.81805 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA2A, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
8.81805 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NUAK1, PTPN1, RELA, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
8.20081 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NUAK1, PTPN1, RELA, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
8.03414 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, ALPL, APEX1, APP, AR, AXL, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD5, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MMP2, MMP9, RELA, RORC, SLC6A4, SMAD3, SRC, TERT |
8.01715 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, HSD17B3, INSR, KDR, MAP2K1, PPARA, RELA, SMAD3, SRC, TEK, TYR |
7.93386 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, ALPL, APEX1, AR, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, INSR, PPARA, RELA, SLC6A4, SRC, TEK |
7.89738 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, APP, AR, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
7.86764 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AR, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GLO1, HCAR2, HSPA1A, IGF1R, KDR, MAP2K1, MET, MMP9, PIM1, PTPN1, RELA, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
7.85089 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGES |
7.82377 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AR, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GLO1, HCAR2, HSPA1A, IGF1R, KDR, MAP2K1, MET, MMP9, PIM1, PPARA, PTPN1, RELA, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
7.82377 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, MMP9, PTGES, RELA, SRC, TERT |
7.66801 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALPL, APEX1, APP, AR, AURKB, AXL, CA2, CA6, CA9, CES1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MMP12, MMP2, MMP9, NUAK1, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, TYR |
7.66188 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGES |
7.55331 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DUSP3, EGFR, ESR1, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP9, NUAK1, PTPN1, RELA, SRC, TEK, XDH |
7.4794 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA2A, AKR1B1, APP, AR, AXL, CYP1B1, DRD2, EGFR, F3, FLT3, GPR35, HSPA1A, INSR, KDR, MAP2K1, MAP3K7, MET, PTPN1, RELA, SRC, TEK, XDH |
7.417 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AR, AXL, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD17B2, PTGES, RELA, RORC, SLC6A4, SRC, TYR |
7.34349 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRA2A, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA2, CA7, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
7.34349 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AR, AURKB, AXL, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GLO1, HCAR2, HSPA1A, IGF1R, KDR, MAP2K1, MMP9, PIM1, PTPN1, RELA, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
7.31793 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, ALPL, APEX1, APP, AR, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD5, EGFR, ESR1, FABP4, FLT3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MMP2, MMP9, NUAK1, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TERT, TOP2A |
7.28175 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ADRA2A, APEX1, APP, AR, AXL, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAP2K1, MET, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SMAD3, SRC, TEK, TERT |
7.28091 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGES |
7.21974 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, APEX1, APP, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TERT |
6.88901 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, APEX1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPR35, HSPA1A, IGF1R, KCNH2, KDR, MAP2K1, MET, MMP12, MMP9, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
6.88901 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA2A, AKR1B1, APEX1, APP, AXL, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, INSR, KCNH2, MET, SMAD3, SRC, TERT |
6.88901 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA2A, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AR, AXL, CACNA1C, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESRRB, F3, FABP4, HSD17B2, IGF1R, INSR, KCNH2, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, RELA, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TYR |
6.88901 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CES1, CES2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD2, EGFR, FABP3, FABP4, FDPS, FUT7, MET, PPARA, PTGES |
6.82428 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19 |
6.79881 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, CES1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, KDR, RELA, SLC6A4, SRC |
6.74884 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, AR, CDC25B, CSNK2A1, DRD2, DRD3, EGFR, ESR1, F3, FLT3, IGF1R, INSR, KDR, MMP12, MMP2, MMP9, PIM1, RELA, TEK, TERT |
6.73763 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA2A, AR, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MMP12, MMP9, PTPN1, RELA, SLC6A4, SMAD3, SRC, TERT, XDH |
6.73717 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, MAP3K7, PIM1, PPARA, RELA, RORC, SRC |
6.73368 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA2A, AR, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, GPR35, HSPA1A, IGF1R, MET, MMP12, MMP9, PTPN1, RELA, SLC6A4, SMAD3, SRC, TERT, XDH |
6.72314 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, APEX1, APP, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TERT |
6.71785 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, APEX1, APP, CACNA1C, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TERT |
6.69856 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALPL, APEX1, APP, AR, AURKB, AXL, CA2, CA9, CACNA1C, CDC25B, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD17B2, HSD17B3, INSR, KDR, MAP2K1, MET, MMP2, MMP9, PIM1, PPARA, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, TYR |
6.69856 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, APP, AR, CYP1A1, CYP1B1, DRD1, DRD5, EGFR, ESR1, FLT3, RORC, SLC6A4, SRC |
6.58551 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, APEX1, APP, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TERT |
6.53399 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, ALPL, APEX1, APP, AR, AXL, CYP1A1, CYP1B1, DRD1, DRD5, EGFR, ESR1, FABP4, FLT3, IGF1R, INSR, KDR, MMP2, RELA, RORC, SLC6A4, SMAD3, SRC |
6.52503 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, PPARA, PTGES |
6.48376 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, APP, AR, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ESRRA, F3, FABP4, FLT3, GPR35, HSPA1A, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP2, MMP9, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
6.44658 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, DRD2, EGFR, ESR1, HCAR2, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
6.37116 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ADRA2A, APP, CYP19A1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, HSPA1A, IGF1R, MAP2K1, MAP3K7, MET, MMP12, MMP2, NUAK1, PPARA, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
6.36942 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, APP, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, RELA, SLC6A4, SRC, TEK, TYR |
6.32446 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PPARA, PTPN1, RELA, SMAD3, SRC, TEK, TERT |
6.27864 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TERT, TOP2A, TYR, XDH |
6.2537 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, KDR, MET, MMP9, PIM1, PTPN1, RELA, SMAD3, SRC, TEK, TERT |
6.18461 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, EGFR, HSPA1A, MAOA |
6.17985 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA2A, APP, AR, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
6.17985 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA2A, APP, AR, CDC25B, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
6.17127 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGES |
6.17127 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, CYP2D6, RORC |
6.14089 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, APP, AR, CDC25B, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESRRB, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MMP9, NUAK1, PPARA, PTPN1, SMAD3, SRC, TEK, XDH |
6.11588 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TERT, TOP2A, TYR, XDH |
6.09561 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, APEX1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GLO1, GPR35, HCAR2, HSPA1A, IGF1R, KCNH2, KDR, MAP2K1, MET, MMP12, MMP9, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
6.06299 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, HSD11B1, HSD17B1, HSD17B2, HSD17B3, MAOA, TYR, XDH |
6.01724 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA2A, APP, AR, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PPARA, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
5.98742 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, APP, AR, CDC25B, DRD1, DRD2, DRD5, EGFR, ESRRB, FABP3, FLT3, INSR, KDR, MAP2K1, MAP3K7, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
5.97479 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA2A, APP, AR, CDC25B, DRD1, DRD2, DRD5, EGFR, ESRRB, FABP3, FLT3, INSR, KDR, MAP2K1, MAP3K7, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
5.97479 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, APP, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, RELA, SLC6A4, SRC, TEK, TYR |
5.87422 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, CA9, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, FABP3, KCNH2, KDR, RELA, SLC6A2, SLC6A4, SRC |
5.83273 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, CES1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, FDPS, HSD17B3, MAOA, TYR |
5.82164 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA2A, APP, AR, AURKB, CDC25B, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
5.81406 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
5.77707 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRA2A, APP, AR, AURKB, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, F3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, MAP2K1, MAP3K7, MET, MMP9, NUAK1, PIM1, PPARA, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
5.77301 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA2A, APP, AR, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PPARA, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
5.76758 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AR, AXL, CYP1B1, DRD1, DRD5, EGFR, ESR1, IGF1R, INSR, MMP2, MMP9, RELA, RORC, SLC6A4, SRC |
5.6992 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA2A, AKR1B1, APP, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, FABP4, GPR35, INSR, KCNH2, MET, SMAD3 |
5.69284 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, KDR, MMP9, PIM1, PTPN1, RELA, SMAD3, SRC, TEK, TERT |
5.64686 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA2A, APP, AR, DRD2, EGFR, FLT3, INSR, KDR, MAP2K1, MAP3K7, PTPN1, SRC, TEK, XDH |
5.60855 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, APEX1, APP, AR, DRD1, DRD5, EGFR, ESR1, FLT3, IGF1R, INSR, MMP2, RELA, SLC6A4, SMAD3, SRC |
5.55793 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
5.5577 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.5577 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.5577 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MET, SRC, TEK |
5.54618 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, APP, DRD1, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TERT |
5.53996 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, APP, AURKB, CDC25B, CYP1A1, DRD2, DRD3, DUSP3, EGFR, INSR, SLC6A4, SRC, TERT |
5.52526 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MET, SRC, TEK |
5.49402 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA2A, APP, AR, AURKB, CDC25B, CSNK2A1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, MAP2K1, MAP3K7, MMP9, NUAK1, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
5.46294 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA2A, APP, AR, AXL, CA2, CYP1B1, DRD2, DRD3, EGFR, ESRRB, F3, HCAR2, HSPA1A, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PIM1, RELA, SMAD3, SRC, TEK, TERT |
5.46294 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA2A, APP, AR, AXL, CA2, CACNA1C, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, ESRRB, F3, GPR35, HCAR2, HSPA1A, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, PIM1, RELA, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
5.46294 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, PTGES |
5.44582 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, APP, DRD1, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TERT |
5.37716 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
5.3707 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, DRD1, DRD2, DRD3, EGFR, HSPA1A, MMP2, PPARA, RELA, SLC6A4, SMAD3, SRC, TEK, TERT, TYR |
5.33936 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD1, DRD2, DRD3, EGFR, INSR, MAOA, SLC6A2, SLC6A4, SMAD3 |
5.33936 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA2A, APP, AR, DRD2, DUSP3, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MAP3K7, PTPN1, SRC, TEK, XDH |
5.30954 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, APP, AR, AXL, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DUSP3, EGFR, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, HSD17B3, INSR, KDR, MAP2K1, MMP9, PIM1, PPARA, RELA, RORC, SMAD3, SRC, TEK, TYR |
5.28464 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, APP, DRD1, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TERT |
5.24942 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, EGFR, FDPS |
5.24942 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APEX1, APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, FDPS, FLT3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, PTPN1, SRC, TEK, XDH |
5.23063 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2, HSD17B3 |
5.22685 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, RELA, SRC |
5.22685 |
[BP] GO:0032787 |
None
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, GLO1, PPARA, PTGES |
5.17555 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AR, AURKB, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, IGF1R, INSR, MAP2K1, MET, MMP12, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TERT, TOP2A |
5.17131 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA2A, AR, CYP19A1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP12, MMP9, PPARA, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
5.13055 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ADRA2A, APP, AXL, CA2, CA7, CACNA1C, CYP19A1, DRD1, DRD2, DRD3, EGFR, GPR35, HCAR2, HSPA1A, INSR, KCNH2, MAP2K1, MMP12, MMP9, PPARA, PTPN1, SLC6A4, SMAD3, SRC, TERT |
5.13055 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK |
5.13055 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, EGFR, F3, INSR, MET, SRC, TEK, XDH |
5.12289 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, APP, DRD1, EGFR, F3, IGF1R, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK, TERT |
5.09589 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRA2A, APP, AR, AURKB, CDC25B, DRD2, DRD5, EGFR, ESR1, ESR2, F3, FLT3, HSPA1A, INSR, MAP2K1, MAP3K7, MET, MMP9, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
5.07557 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, APP, AURKB, CSNK2A1, CYP1B1, CYP2D6, DRD2, DRD3, DRD5, DUSP3, ESR1, FABP4, GPR35, IGF1R, MET, MMP9, PIM1, PPARA, PTPN1, SRC |
5.01341 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, ADRA2A, APP, AXL, CA2, CYP19A1, DRD1, DRD2, DRD3, EGFR, HCAR2, INSR, KCNH2, MMP12, SLC6A4, SMAD3, SRC, TERT |
4.95413 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, DRD2, DRD3, EGFR, ESR1, PPARA, RORC, SLC6A4, SRC, TOP2A |
4.92534 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2C19 |
4.90092 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APEX1, APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, FDPS, FLT3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, PTPN1, SRC, TEK, XDH |
4.85597 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, EGFR, ESR1, F3, FABP4, KDR, MAP2K1, MET, MMP12, PPARA, RELA, SMAD3, TEK |
4.82417 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, CYP1A1, DRD3, FABP3, FDPS, FLT3, HCAR2, PPARA, RORC, SRC, TEK |
4.79108 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AR, AURKB, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, KDR, MAP2K1, MET, MMP12, PPARA, RELA, RORC, SMAD3, SRC, TERT, TOP2A |
4.78518 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, EGFR, FDPS |
4.78504 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CES1, CYP19A1, FDPS, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
4.76087 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP1B1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NUAK1, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
4.73653 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, SLC6A4 |
4.70023 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, DRD1, DRD2, DRD3, DRD5, EGFR, SLC6A4 |
4.70023 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
4.66888 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRA2A, AKR1B1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP2, MMP9, NUAK1, PPARA, PTPN1, RELA, SMAD3, SRC, TEK, TERT, XDH |
4.63423 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AR, AXL, CDC25B, CYP19A1, CYP1A1, DRD1, DRD5, EGFR, ESR1, ESRRB, HSD17B2, HSD17B3, INSR, MAP2K1, MMP2, MMP9, SLC6A4, SRC, TOP2A |
4.60668 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
4.5618 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA2A, APP, AR, CDC25B, DRD1, DRD2, DUSP3, EGFR, ESRRB, FABP4, FLT3, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MMP9, PPARA, PTPN1, SRC, TEK, XDH |
4.46674 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, APP, DRD1, DRD5, EGFR, IGF1R, INSR, MMP2, RELA, SLC6A4, SRC |
4.43556 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, EGFR, HCAR2, KDR, SRC |
4.43127 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, RELA, SRC |
4.42922 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, SLC6A4, SMAD3, SRC, TEK, TERT |
4.36787 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AR, AURKB, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, INSR, MAP2K1, MET, MMP12, PPARA, RELA, RORC, SMAD3, SRC, TERT, TOP2A |
4.36682 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APEX1, APP, CDC25B, CYP1A1, DRD3, DUSP3, INSR, TERT |
4.36184 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APEX1, APP, AURKB, CDC25B, CYP1A1, DRD3, DUSP3, EGFR, HSPA1A, INSR, MAP2K1, PIM1, SMAD3, TERT, TOP2A |
4.35978 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
4.33513 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, GPR35, HCAR2, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, TYR, XDH |
4.30672 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, APEX1, APP, AR, AURKB, CSNK2A1, CYP2D6, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HCAR2, HSPA1A, IGF1R, KDR, MAP2K1, MET, MMP12, MMP9, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TERT, XDH |
4.28774 |
[BP] GO:0050801 |
ion homeostasis
|
APP, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, FABP3, GPR35, KCNH2, SMAD3 |
4.28635 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, SLC6A4, SMAD3, SRC, TEK, TERT |
4.2679 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, ADRA2A, DUSP3, EGFR, FLT3, IGF1R, INSR, MAP2K1, MAP3K7, PTPN1, SRC |
4.22666 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, DRD5, SLC6A4 |
4.2235 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, KDR, SRC |
4.20737 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, AR, AURKB, AXL, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, F3, FLT3, FUT7, GLO1, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RELA, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
4.20064 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3, DRD5 |
4.18541 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA2A, APP, AR, CDC25B, DRD2, EGFR, ESRRB, FLT3, INSR, KDR, MAP2K1, MAP3K7, MMP9, PTPN1, SRC, TEK, XDH |
4.17055 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2C19, CYP2D6, FABP3, FABP4, FUT7, HSPA1A, MAOA, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
4.15986 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA2A, DRD1, DRD5, EGFR, SLC6A4, SRC, TEK |
4.15234 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, DRD2, EGFR, ESR1, FABP4, HSPA1A, MAP3K7, MMP12, MMP2, PPARA, PTPN1, RELA, SMAD3, SRC, TEK |
4.14237 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, APP, DRD1, DRD5, EGFR, IGF1R, INSR, MMP2, RELA, SLC6A4, SRC |
4.12156 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, DRD1, EGFR, KCNH2, KDR, RELA, SRC |
4.08395 |
[BP] GO:0070920 |
None
|
EGFR, ESR1, MAP2K1, TERT |
4.08395 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3, SLC6A4 |
4.08395 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD5, EGFR, HSPA1A, MAP2K1, MAP3K7, MMP2, MMP9, NUAK1, PPARA, PTGES, PTPN1, RELA, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A |
4.03324 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA2A, APP, AR, CDC25B, CSNK2A1, DRD2, EGFR, ESR1, F3, FLT3, HSPA1A, INSR, KDR, MAP2K1, MAP3K7, MMP9, PTPN1, RELA, SMAD3, SRC, TEK, XDH |
3.97664 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, DRD2, MMP2, PPARA, SLC6A4, SMAD3, SRC, TEK, TERT |
3.96709 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA2A, AKR1B1, APP, AR, AXL, CA1, CA2, CACNA1C, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SMAD3, SRC, TEK |
3.96378 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA2A, APP, AR, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MMP9, PTPN1, SRC, TEK, XDH |
3.94175 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC, SRC |
3.93489 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, DRD1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK |
3.8987 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA2A, APP, AR, CDC25B, DRD1, DRD2, DUSP3, EGFR, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MMP9, NUAK1, PTPN1, RELA, SRC, TEK, XDH |
3.89786 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRA2A, AKR1B1, AXL, CACNA1C, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PTPN1, RELA, SRC, TEK |
3.83515 |
[BP] GO:0045776 |
None
|
ADORA1, DRD2, DRD3, DRD5, PPARA |
3.83295 |
[BP] GO:0051726 |
regulation of cell cycle
|
APEX1, APP, AURKB, CDC25B, CSNK2A1, CYP1A1, DRD2, DRD3, DUSP3, EGFR, HSPA1A, INSR, MAP2K1, PIM1, SLC6A4, SMAD3, SRC, TERT, TOP2A |
3.82893 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, RELA, SRC |
3.81694 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, DRD1, DRD2, EGFR |
3.81609 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AR, AURKB, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, IGF1R, INSR, KDR, MAP2K1, MET, MMP12, PPARA, RELA, RORC, SMAD3, SRC, TERT, TOP2A |
3.81609 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA2A, APP, AR, CDC25B, DRD2, EGFR, FLT3, INSR, KDR, MAP2K1, MAP3K7, MMP9, PTPN1, SRC, TEK, XDH |
3.81609 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
APP, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, GPR35, KCNH2, SMAD3 |
3.81541 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3, MAOA |
3.79665 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3, MAOA |
3.79665 |
[BP] GO:0018958 |
None
|
AKR1B1, DRD1, DRD2, DRD3, MAOA, TYR |
3.78482 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, ADRA2A, APP, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, MAP2K1, MAP3K7, PTPN1, SRC, TEK |
3.76935 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA2A, APP, AURKB, CDC25B, DRD2, DRD5, EGFR, ESR1, F3, FLT3, HSPA1A, INSR, MAP2K1, MAP3K7, PTPN1, SMAD3, SRC, TEK, TERT, XDH |
3.76886 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA2A, AR, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, HSPA1A, IGF1R, MET, MMP12, MMP9, PTPN1, RELA, SMAD3, SRC, TERT, XDH |
3.75208 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, CYP1A1, DRD2, DRD5, EGFR, PPARA, SMAD3 |
3.74609 |
[BP] GO:0048732 |
gland development
|
AR, CSNK2A1, CYP19A1, EGFR, INSR, MAP2K1, RELA, SMAD3, TYR |
3.74139 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, APEX1, APP, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, GLO1, HCAR2, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
3.74048 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2C19, CYP2D6 |
3.74048 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, GLO1, PIM1, PPARA, PTGES, TYR |
3.71871 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, DRD3, MAOA |
3.70335 |
[BP] GO:0010038 |
response to metal ion
|
APP, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, MMP9, PTGES, TERT |
3.6672 |
[BP] GO:1904063 |
None
|
ADRA2A, DRD2, DRD3, GPR35, KCNH2, MMP9 |
3.65013 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, PTGES, RELA, SLC6A4, SRC |
3.63639 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.63062 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MAP3K7, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK |
3.60495 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PTPN1, SRC, TEK |
3.51336 |
[BP] GO:0051254 |
None
|
APP, AR, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, INSR, MAP2K1, MET, MMP12, PPARA, RELA, RORC, SMAD3, SRC, TERT, TOP2A |
3.5096 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, ADRA2A, APP, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, MAP2K1, MAP3K7, PTPN1, SRC |
3.50602 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, ADRA2A, EGFR, FLT3, INSR, MAP2K1, MAP3K7, PTPN1, SRC |
3.46118 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, ADRA2A, APP, AURKB, CDC25B, DRD2, DUSP3, EGFR, FABP4, FLT3, IGF1R, INSR, MAP2K1, MAP3K7, PTPN1, SRC, TEK |
3.45295 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AR, AXL, CDC25B, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, HSD17B3, INSR, MAP2K1, SRC |
3.45043 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, ADRA2A, DRD2, DRD3, GPR35, KCNH2, MMP9 |
3.42776 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.42221 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, APP, AXL, CYP1B1, EGFR, HSPA1A, MMP9, RELA, SRC |
3.41615 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, AR, CYP1B1, DRD2, FABP3, HSPA1A, MAP2K1, PTGES, SLC6A4, SMAD3, TERT, XDH |
3.41615 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, ADRA2A, APEX1, CSNK2A1, EGFR, ESRRB, HCAR2, HSPA1A, INSR, KDR, MAP3K7, MET, PPARA, PTPN1, RELA, SMAD3 |
3.40499 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, CYP19A1, ESR1, HSD17B2, HSD17B3, INSR, MAP2K1, SRC |
3.39917 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, ADRA2A, APP, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, GPR35, KCNH2, MMP9, SLC6A4 |
3.39573 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
DRD2, DRD3, DUSP3, ESR1, HSPA1A, IGF1R, MET, MMP9, PTPN1, RELA, SRC, XDH |
3.38399 |
[BP] GO:0050890 |
None
|
ADORA1, APP, DRD1, DRD2, DRD3, DRD5, EGFR, INSR, SLC6A4 |
3.37824 |
[BP] GO:0034766 |
None
|
ADRA2A, DRD2, DRD3, GPR35, KCNH2, MMP9 |
3.37244 |
[BP] GO:0003013 |
None
|
ADORA1, ADRA2A, DRD1, DRD5, EGFR, SLC6A4, SRC, TEK |
3.36624 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, APP, FABP3, IGF1R, INSR, PPARA, RELA, SRC, TEK |
3.36624 |
[BP] GO:0090068 |
positive regulation of cell cycle process
|
APEX1, APP, AURKB, CDC25B, CYP1A1, DRD2, DRD3, INSR, TERT |
3.36077 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
APP, DRD2, DUSP3, EGFR, KDR, MAP2K1, PTPN1, SRC, TEK |
3.36077 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.35728 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.35728 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, APP, AR, CDC25B, DRD2, EGFR, ESR1, F3, FLT3, HSPA1A, INSR, KDR, MAP2K1, MAP3K7, MMP9, PTPN1, SMAD3, SRC, TEK, XDH |
3.33163 |
[BP] GO:0001975 |
None
|
DRD1, DRD2, DRD3, DRD5 |
3.30711 |
[BP] GO:0008217 |
None
|
ADORA1, AR, DRD2, DRD3, DRD5, PPARA, SMAD3 |
3.30404 |
[BP] GO:0045893 |
None
|
APP, AR, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MAP2K1, MET, MMP12, PPARA, RELA, RORC, SMAD3, SRC, TERT, TOP2A |
3.30404 |
[BP] GO:1903508 |
None
|
APP, AR, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MAP2K1, MET, MMP12, PPARA, RELA, RORC, SMAD3, SRC, TERT, TOP2A |
3.30404 |
[BP] GO:1902680 |
None
|
APP, AR, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, INSR, MAP2K1, MET, MMP12, PPARA, RELA, RORC, SMAD3, SRC, TERT, TOP2A |
3.30104 |
[BP] GO:0042752 |
None
|
ADORA1, DRD2, DRD3, PPARA, RORC, TOP2A |
3.29174 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA2A, APEX1, APP, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, GLO1, HCAR2, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
3.28404 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AR, AURKB, AXL, DRD2, DRD3, ESR1, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MET, MMP1, MMP9, SMAD3, SRC, TEK |
3.28404 |
[BP] GO:0055080 |
cation homeostasis
|
APP, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, GPR35, KCNH2, SMAD3 |
3.27836 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, F3, INSR, MET, SRC, TEK |
3.26018 |
[BP] GO:0034763 |
None
|
ADRA2A, DRD2, DRD3, GPR35, KCNH2, MMP9 |
3.25032 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, GLO1, PIM1, PPARA, PTGES, TYR |
3.24877 |
[BP] GO:0032872 |
regulation of stress-activated MAPK cascade
|
APP, DUSP3, EGFR, IGF1R, MAP2K1, MAP3K7, PTPN1, XDH |
3.24877 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, DRD1, DRD2, DRD3, FABP3, KCNH2, PPARA, SLC6A2, SLC6A4 |
3.24852 |
[BP] GO:0070302 |
regulation of stress-activated protein kinase signaling cascade
|
APP, DUSP3, EGFR, IGF1R, MAP2K1, MAP3K7, PTPN1, XDH |
3.23708 |
[BP] GO:1904062 |
None
|
ADRA2A, APP, CACNA1C, DRD1, DRD2, DRD3, GPR35, KCNH2, MMP9 |
3.2331 |
[BP] GO:0010628 |
positive regulation of gene expression
|
APP, AR, DRD1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, ESRRB, HSPA1A, INSR, MAP2K1, MET, MMP12, PPARA, RELA, RORC, SLC6A4, SMAD3, SRC, TERT, TOP2A |
3.21554 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3, MAOA |
3.20477 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, ADRA2A, CDC25B, DRD2, EGFR, FLT3, INSR, MAP2K1, MAP3K7, PTPN1, SRC, TEK |
3.179 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.16823 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CES1, CES2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, FABP3, GLO1, PIM1, PPARA, PTGES, TYR |
3.16731 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, RELA |
3.1509 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CES1, CSNK2A1, CYP19A1, CYP1A1, FDPS, HSD11B1, HSD17B1, HSD17B2, HSD17B3, PTGES |
3.14682 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
3.13991 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AR, AURKB, CYP1A1, EGFR, ESR1, FLT3, MAP2K1, MET, PIM1, SRC, TEK, TYR |
3.11881 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, DRD3, EGFR, HCAR2 |
3.11307 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, RELA, SRC |
3.08612 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, HCAR2, MMP12, SLC6A4, SRC |
3.08353 |
[BP] GO:0007191 |
None
|
DRD1, DRD3, DRD5 |
3.08272 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, CSNK2A1, DRD1, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, SRC, TEK, TOP2A |
3.04478 |
[BP] GO:0045744 |
None
|
ADRA2A, DRD2, DRD3, MET |
3.04478 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
ADORA3, APP, AR, CYP1B1, ESR1, ESR2, HSPA1A, MAP3K7, PIM1, RELA |
3.03065 |
[BP] GO:1900542 |
None
|
ADRA2A, DRD1, DRD2, DRD3, DRD5, ESRRB, INSR, PPARA |
3.01496 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRA2A, CACNA1C, DRD1, DRD2, DRD3, DRD5, EGFR, KDR |
3.00439 |
[BP] GO:0007611 |
None
|
APP, DRD1, DRD2, DRD3, DRD5, EGFR, INSR, SLC6A4 |
3.00439 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, DRD2 |
2.99542 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, DRD2, MMP12, PPARA, SMAD3, TEK |
2.97343 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, CYP1A2, CYP2A6, CYP2C19, CYP2D6, MAOA |
2.96868 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
2.96188 |
[BP] GO:0032147 |
activation of protein kinase activity
|
ADORA1, ADRA2A, DRD2, EGFR, INSR, MAP2K1, MAP3K7, PTPN1, SRC |
2.96188 |
[BP] GO:1902893 |
None
|
PPARA, RELA, SMAD3, TERT |
2.95331 |
[BP] GO:0010907 |
None
|
ESRRB, INSR, PPARA, SRC |
2.95331 |
[BP] GO:0006140 |
None
|
ADRA2A, DRD1, DRD2, DRD3, DRD5, ESRRB, INSR, PPARA |
2.94056 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, ADRA2A, AURKB, CDC25B, DRD2, EGFR, FLT3, INSR, MAP2K1, MAP3K7, PTPN1, SRC, TEK |
2.93857 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, APP, AR, AXL, CDC25B, CES1, CYP1A1, DRD1, DRD2, EGFR, ESR1, ESRRB, FABP4, FLT3, FUT7, GLO1, KDR, MAP2K1, MET, MMP2, MMP9, RORC, SMAD3, SRC, TEK, TERT, TOP2A |
2.93818 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1, HSD17B3 |
2.92835 |
[BP] GO:1901654 |
None
|
AKR1B1, AR, CA9, CSNK2A1, EGFR, RELA, SRC |
2.87985 |
[BP] GO:0008306 |
None
|
APP, DRD1, DRD2, DRD3, DRD5 |
2.873 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR, RELA |
2.86279 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, EGFR |
2.86279 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2A6, CYP2C19 |
2.86092 |
[BP] GO:0015872 |
None
|
DRD1, SLC6A2, SLC6A4 |
2.86092 |
[BP] GO:0046960 |
None
|
DRD1, DRD5 |
2.85515 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.85515 |
[BP] GO:0007189 |
None
|
ADRA2A, DRD1, DRD2, DRD3, DRD5 |
2.85515 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, APEX1, APP, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
2.85167 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, DUSP3, EGFR, FLT3, IGF1R, INSR, MAP2K1, MAP3K7, PTPN1, SRC |
2.85167 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, ADRA2A, APP, CA2, CACNA1C, DRD2, DRD3, EGFR, HCAR2, MMP12, PTPN1, SMAD3, SRC |
2.83149 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, APP, AR, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MMP9, NUAK1, PTPN1, RELA, SMAD3, SRC, TEK, XDH |
2.8233 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
APP, CACNA1C, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, GPR35, SMAD3 |
2.80212 |
[BP] GO:0097746 |
None
|
ADORA1, ADRA2A, DRD1, DRD5, EGFR, SLC6A4 |
2.80212 |
[BP] GO:0035296 |
None
|
ADORA1, ADRA2A, DRD1, DRD5, EGFR, SLC6A4 |
2.80212 |
[BP] GO:0007212 |
None
|
DRD1, DRD2, DRD3, DRD5 |
2.78698 |
[BP] GO:0032467 |
None
|
AURKB, CDC25B, DRD2, DRD3 |
2.78698 |
[BP] GO:0032413 |
None
|
ADRA2A, DRD2, DRD3, GPR35, MMP9 |
2.78405 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, ADRA2A, CDC25B, DRD2, EGFR, FLT3, INSR, MAP2K1, MAP3K7, PTPN1, SRC |
2.77935 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.77524 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
2.77524 |
[BP] GO:0060158 |
None
|
DRD1, DRD2, DRD5 |
2.77524 |
[BP] GO:0051952 |
None
|
ADORA1, ADRA2A, DRD1, DRD2, DRD3 |
2.76352 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, TERT |
2.76352 |
[BP] GO:0048806 |
genitalia development
|
AXL, CYP19A1, ESR1, HSD17B3 |
2.75385 |
[BP] GO:0014075 |
None
|
DRD1, DRD2, DRD3, DRD5 |
2.75385 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA2A, CACNA1C, DRD2, DRD3, EGFR, GPR35, HCAR2, KCNH2, SMAD3 |
2.75197 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, ADRA2A, EGFR, HCAR2, MET, PPARA, RELA, SMAD3 |
2.71939 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, CYP2D6, MET, MMP9, PPARA, SMAD3, SRC, TERT |
2.71939 |
[BP] GO:0032870 |
cellular response to hormone stimulus
|
ADRA2A, APEX1, AR, EGFR, ESR1, FLT3, INSR, RELA, SRC |
2.71939 |
[BP] GO:0046683 |
response to organophosphorus
|
APEX1, APP, RELA, SLC6A4, TEK, TYR |
2.7084 |
[BP] GO:0009653 |
anatomical structure morphogenesis
|
APP, AR, AXL, CA2, CA9, CACNA1C, CYP1B1, DRD2, EGFR, ESR1, INSR, MET, MMP2, RELA, SLC6A4, SMAD3, SRC, TEK |
2.70032 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.68776 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
2.68776 |
[BP] GO:0050880 |
None
|
ADORA1, ADRA2A, DRD1, DRD5, EGFR, SLC6A4 |
2.67585 |
[BP] GO:0035150 |
None
|
ADORA1, ADRA2A, DRD1, DRD5, EGFR, SLC6A4 |
2.65861 |
[BP] GO:0034762 |
None
|
ADRA2A, APP, CA2, CACNA1C, DRD1, DRD2, DRD3, GPR35, KCNH2, MMP9 |
2.65272 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
APP, DRD2, EGFR, KDR, MAP2K1, SRC, TEK |
2.6521 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, ADRA2A, EGFR, FLT3, INSR, MAP2K1, MAP3K7, PTPN1, SRC |
2.6521 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, APEX1, APP, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
2.64843 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA2A, APP, AR, CDC25B, DRD2, EGFR, FLT3, INSR, KDR, MAP2K1, MAP3K7, MMP9, PTPN1, SRC, TEK, XDH |
2.64583 |
[BP] GO:0050793 |
regulation of developmental process
|
APP, AR, AXL, CA2, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, ESRRB, F3, INSR, KDR, MAP2K1, NUAK1, PIM1, PPARA, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
2.64568 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, EGFR, RELA, TYR |
2.62764 |
[BP] GO:0007623 |
circadian rhythm
|
DRD2, DRD3, EGFR, PPARA, RORC, SLC6A4 |
2.61476 |
[BP] GO:0007612 |
None
|
APP, DRD1, DRD2, DRD3, DRD5, INSR |
2.61476 |
[BP] GO:0071396 |
cellular response to lipid
|
AR, AXL, EGFR, ESR1, FLT3, RELA, RORC, SLC6A4, SRC |
2.61257 |
[BP] GO:1903798 |
None
|
EGFR, ESR1, MAP2K1 |
2.60918 |
[BP] GO:0051937 |
None
|
DRD1, SLC6A2, SLC6A4 |
2.60918 |
[BP] GO:0032410 |
None
|
ADRA2A, DRD2, DRD3, GPR35, MMP9 |
2.60918 |
[BP] GO:0043268 |
None
|
ADORA1, ADRA2A, DRD1, KCNH2 |
2.6087 |
[BP] GO:1901224 |
None
|
APP, EGFR, MAP3K7, RELA |
2.6087 |
[BP] GO:0055065 |
metal ion homeostasis
|
APP, CACNA1C, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, GPR35, KCNH2, SMAD3 |
2.58867 |
[BP] GO:1901989 |
None
|
APEX1, APP, CDC25B, CYP1A1, TERT |
2.58867 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
APP, AR, AXL, CA2, CYP1B1, DRD2, DRD3, EGFR, ESR1, ESRRA, F3, INSR, KDR, MAP2K1, PIM1, RELA, SLC6A4, SMAD3, SRC, TEK, TERT, XDH |
2.57488 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.57291 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DUSP3, EGFR, HSPA1A, IGF1R, MAP2K1, MAP3K7, MET, NUAK1, PTPN1, TERT, XDH |
2.57291 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, DRD3, PPARA, SMAD3, TEK |
2.57111 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, ADRA2A, CACNA1C, DRD2, DRD3, EGFR, HCAR2, MMP12, SRC |
2.57026 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
2.56683 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, MET, MMP9, PPARA, SRC, TERT |
2.56683 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AR, AXL, CYP1A1, DRD1, DRD5, EGFR, ESR1, SLC6A4, SRC |
2.56274 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ADRA2A, APEX1, APP, AR, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, MMP9, NUAK1, PIM1, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
2.55505 |
[BP] GO:0040008 |
regulation of growth
|
APP, AR, CSNK2A1, DRD2, DRD3, EGFR, ESR2, HSPA1A, INSR, PIM1, SLC6A4, SMAD3 |
2.55505 |
[BP] GO:0042058 |
None
|
ADORA1, ADRA2A, APP, EGFR, MMP9 |
2.5518 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
AR, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.54728 |
[BP] GO:0051172 |
None
|
ADRA2A, APEX1, APP, AR, AURKB, CSNK2A1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, MMP12, MMP9, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TERT, XDH |
2.54717 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.54239 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APEX1, APP, IGF1R, INSR, RELA, SRC |
2.5368 |
[BP] GO:0007200 |
None
|
ADRA2A, DRD1, DRD2, DRD5, ESR1 |
2.53425 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, DRD1, DRD2, DRD3, EGFR, RELA, TYR |
2.52152 |
[BP] GO:0060359 |
None
|
DRD1, DRD2, DRD3, DRD5, RELA |
2.51456 |
[BP] GO:0045761 |
None
|
ADRA2A, DRD2, DRD3, DRD5 |
2.51456 |
[BP] GO:0097366 |
None
|
DRD1, DRD2, DRD3, DRD5 |
2.51456 |
[BP] GO:0060341 |
regulation of cellular localization
|
ADRA2A, APP, AR, CACNA1C, CSNK2A1, DRD1, DRD2, DRD3, EGFR, MAP2K1, PTPN1, SMAD3, SRC, TERT |
2.51256 |
[BP] GO:2001234 |
negative regulation of apoptotic signaling pathway
|
AR, HSPA1A, MMP9, PTPN1, RELA, SRC, TERT |
2.50508 |
[BP] GO:0014074 |
response to purine-containing compound
|
APEX1, APP, RELA, SLC6A4, TEK, TYR |
2.47928 |
[BP] GO:0009410 |
None
|
DRD1, DRD2, DRD3, DRD5, EGFR, RELA |
2.47928 |
[BP] GO:0033590 |
None
|
EGFR, RELA |
2.4756 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.4756 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.4756 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.4756 |
[BP] GO:0002520 |
None
|
CACNA1C, SMAD3 |
2.4756 |
[BP] GO:0030003 |
cellular cation homeostasis
|
APP, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3 |
2.47403 |
[BP] GO:0051094 |
positive regulation of developmental process
|
APP, AR, AXL, CA2, CYP1B1, DRD2, ESRRB, F3, INSR, KDR, MAP2K1, PIM1, RELA, SMAD3, SRC, TEK, TERT |
2.46335 |
[BP] GO:0019933 |
None
|
ADRA2A, DRD1, DRD2, DRD3, DRD5 |
2.46294 |
[BP] GO:0006874 |
cellular calcium ion homeostasis
|
APP, CACNA1C, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3 |
2.43869 |
[BP] GO:1901360 |
None
|
ACHE, AKR1B1, AKR1B10, AOX1, APEX1, APP, AR, CES1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, FDPS, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, MAOA, MAP3K7, PPARA, RELA, RORC, SMAD3, TERT, TOP2A, TYR, XDH |
2.42874 |
[BP] GO:0008542 |
None
|
APP, DRD1, DRD2, DRD3 |
2.42731 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, AR, CA2, EGFR, FLT3, RELA, SRC |
2.42629 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADRA2A, APEX1, APP, AR, AURKB, CSNK2A1, CYP2D6, DRD2, DRD3, DUSP3, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, MET, MMP12, MMP9, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TERT, XDH |
2.42372 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, ADRA2A, CACNA1C, CYP19A1, DRD2, DRD3, EGFR, HCAR2, MMP12, SLC6A4, SRC |
2.41485 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, ADRA2A, APP, AR, CACNA1C, CSNK2A1, DRD2, DRD3, EGFR, HCAR2, MMP12, PTPN1, SMAD3, SRC, TERT |
2.40742 |
[BP] GO:0006873 |
cellular ion homeostasis
|
APP, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3 |
2.39581 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CYP19A1, EGFR, ESR1, FABP4, PPARA, RELA, SMAD3, TEK |
2.38939 |
[BP] GO:0051591 |
None
|
APEX1, APP, RELA, TEK, TYR |
2.36934 |
[BP] GO:0010906 |
None
|
ESRRB, INSR, PPARA, RORC, SRC |
2.36934 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA2A, DRD1, DRD2, DRD3, DRD5 |
2.35419 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.35419 |
[BP] GO:0007617 |
None
|
APP, DRD1, DRD5 |
2.35419 |
[BP] GO:0055074 |
calcium ion homeostasis
|
APP, CACNA1C, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3 |
2.35396 |
[BP] GO:0045934 |
None
|
ADRA2A, APEX1, AR, AURKB, DRD2, DRD3, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, PPARA, RELA, RORC, SMAD3, SRC, TERT |
2.34014 |
[BP] GO:0001819 |
positive regulation of cytokine production
|
ADRA2A, CYP1B1, DRD2, HSPA1A, MAP3K7, MMP12, RELA, SMAD3, SRC |
2.34014 |
[BP] GO:0030817 |
None
|
ADRA2A, DRD1, DRD2, DRD3, DRD5 |
2.33659 |
[BP] GO:0043266 |
None
|
ADORA1, ADRA2A, DRD1, DRD2, KCNH2 |
2.33659 |
[BP] GO:0009889 |
regulation of biosynthetic process
|
ADORA3, ADRA2A, APEX1, APP, AR, AURKB, CA9, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FDPS, GLO1, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, PIM1, PPARA, RELA, RORC, SMAD3, SRC, TERT, TOP2A |
2.32006 |
[BP] GO:0072503 |
cellular divalent inorganic cation homeostasis
|
APP, CACNA1C, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3 |
2.31907 |
[BP] GO:1901184 |
None
|
ADORA1, ADRA2A, APP, EGFR, MMP9 |
2.31857 |
[BP] GO:0010676 |
None
|
ESRRB, INSR, PPARA, SRC |
2.31572 |
[BP] GO:0050994 |
None
|
ADORA1, ADRA2A, HCAR2, PPARA |
2.31572 |
[BP] GO:0050730 |
None
|
ADORA1, ADRA2A, APP, EGFR, FLT3, PTPN1, SRC |
2.30708 |
[BP] GO:0019935 |
None
|
ADRA2A, DRD1, DRD2, DRD3, DRD5 |
2.30267 |
[BP] GO:0000904 |
cell morphogenesis involved in differentiation
|
AR, AXL, MET, SRC, TEK |
2.30267 |
[BP] GO:0019219 |
regulation of nucleobase-containing compound metabolic process
|
ADORA3, ADRA2A, APEX1, APP, AR, AURKB, CA9, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, FABP4, GLO1, HSPA1A, IGF1R, INSR, MAP2K1, MAP3K7, MET, MMP12, PIM1, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TERT, TOP2A |
2.30241 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3 |
2.30241 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.30241 |
[BP] GO:0007632 |
None
|
APP, DRD1, DRD2, DRD3 |
2.29078 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.29069 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.29069 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.29069 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.29069 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, CES1, CYP19A1, FDPS, HSD17B3, TYR |
2.28733 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
CYP1A1, CYP1A2, CYP1B1, DRD5, EGFR |
2.27324 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.2673 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.2673 |
[BP] GO:2001237 |
negative regulation of extrinsic apoptotic signaling pathway
|
AR, HSPA1A, RELA, SRC, TERT |
2.25599 |
[BP] GO:0015844 |
None
|
DRD1, SLC6A2, SLC6A4 |
2.24903 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.24903 |
[BP] GO:0010564 |
regulation of cell cycle process
|
APEX1, APP, AURKB, CDC25B, CSNK2A1, CYP1A1, DRD2, DRD3, EGFR, HSPA1A, INSR, TERT |
2.24064 |
[BP] GO:0032922 |
None
|
DRD2, DRD3, PPARA, RORC |
2.24064 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.23866 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.23866 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.23866 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, CA1, CSNK2A1, DRD2, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KDR, MAP3K7, MET, MMP2, MMP9, PTPN1, RELA, SMAD3, SRC, TEK |
2.22546 |
[BP] GO:0046686 |
response to cadmium ion
|
CYP1A2, EGFR, MMP9, TERT |
2.22084 |
[BP] GO:0046328 |
regulation of JNK cascade
|
APP, DUSP3, EGFR, IGF1R, MAP3K7, PTPN1 |
2.20761 |
[BP] GO:0051091 |
positive regulation of DNA binding transcription factor activity
|
APP, AR, ESR1, ESR2, HSPA1A, MAP3K7, RELA |
2.2057 |
[BP] GO:1902895 |
None
|
RELA, SMAD3, TERT |
2.2057 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.2057 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.2057 |
[BP] GO:0050995 |
None
|
ADORA1, ADRA2A, HCAR2 |
2.2057 |
[BP] GO:0072347 |
None
|
DRD2, DRD3, DRD5, RELA |
2.19873 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.19873 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
APP, EGFR, INSR, KDR, RELA, SMAD3, SRC |
2.18801 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, ADRA2A, CACNA1C, CYP19A1, DRD2, DRD3, EGFR, HCAR2, MMP12, SLC6A4, SRC |
2.17929 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, ADRA2A, APP, AR, CDC25B, CSNK2A1, DRD1, DRD2, DUSP3, EGFR, ESR1, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MMP9, NUAK1, PTPN1, RELA, SMAD3, SRC, TEK, XDH |
2.17929 |
[BP] GO:0050678 |
None
|
AR, EGFR, F3, KDR, MMP12, SMAD3, TEK, XDH |
2.17671 |
[BP] GO:0050708 |
None
|
ACHE, ADRA2A, CACNA1C, DRD2, DRD3, EGFR, HCAR2, MMP12, SRC |
2.15957 |
[BP] GO:0045944 |
None
|
APP, AR, DRD2, DRD3, EGFR, ESR1, ESRRA, ESRRB, MET, MMP12, PPARA, RELA, SMAD3, TERT, TOP2A |
2.15957 |
[BP] GO:0051953 |
None
|
ADORA1, ADRA2A, DRD2 |
2.15689 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.15689 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.15689 |
[BP] GO:0045088 |
regulation of innate immune response
|
DRD2, ESR1, HSPA1A, MAP3K7, MMP12, MMP2, PTPN1, RELA, SRC |
2.15619 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, EGFR |
2.15153 |
[BP] GO:0070988 |
demethylation
|
APEX1, CYP1A1, CYP1A2, CYP2D6 |
2.15153 |
[BP] GO:0034765 |
None
|
ADRA2A, APP, CACNA1C, DRD1, DRD2, DRD3, GPR35, KCNH2, MMP9 |
2.15112 |
[BP] GO:0050679 |
None
|
AR, EGFR, F3, KDR, MMP12, TEK |
2.14413 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CACNA1C, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, GLO1, GPR35, HCAR2, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
2.12968 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.10718 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.10718 |
[BP] GO:0010605 |
negative regulation of macromolecule metabolic process
|
APEX1, APP, AR, AURKB, CSNK2A1, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, FABP4, HSPA1A, IGF1R, KDR, MAP2K1, MMP12, MMP9, PPARA, PTPN1, RELA, RORC, SMAD3, SRC, TERT, XDH |
2.10718 |
[BP] GO:0031279 |
None
|
ADRA2A, DRD2, DRD3, DRD5 |
2.10196 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, DRD2, EGFR, HCAR2, MMP12, SRC |
2.09916 |
[BP] GO:0001503 |
ossification
|
ALPL, EGFR, MMP2, MMP9, TEK |
2.09105 |
[BP] GO:0051339 |
None
|
ADRA2A, DRD2, DRD3, DRD5 |
2.07872 |
[BP] GO:1901222 |
None
|
APP, EGFR, MAP3K7, RELA |
2.07872 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, PPARA, SMAD3, TEK |
2.07667 |
[BP] GO:0051704 |
multi-organism process
|
APP, AXL, CYP1A1, DRD3, EGFR, FDPS, HSPA1A, INSR, KDR, MAP2K1, MET, MMP1, MMP12, RELA, SLC6A4, SMAD3, SRC |
2.0707 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.06377 |
[BP] GO:0030814 |
None
|
ADRA2A, DRD1, DRD2, DRD3, DRD5 |
2.06377 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.06377 |
[BP] GO:0061370 |
testosterone biosynthetic process
|
CYP19A1, HSD17B3 |
2.06377 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.06377 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.06377 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.06377 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.06377 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, APP, AXL, CA2, CYP19A1, DRD2, DUSP3, ESR1, ESRRA, HCAR2, HSPA1A, MAP3K7, MMP12, MMP2, PTPN1, RELA, SMAD3, SRC |
2.06205 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA2A, DRD1, DRD2, DRD3, DRD5 |
2.06205 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
APP, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, DRD5, ESR1, GPR35, SMAD3 |
2.03995 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, DRD1, DRD2, MET |
2.03921 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, ADRA2A, CACNA1C, CYP19A1, DRD2, EGFR, HCAR2 |
2.03746 |
[BP] GO:0009896 |
positive regulation of catabolic process
|
ADRA2A, CSNK2A1, ESRRB, HSPA1A, INSR, KDR, MAP3K7, PPARA, PTPN1 |
2.03746 |
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.02757 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.02757 |
[BP] GO:0030802 |
None
|
ADRA2A, DRD1, DRD2, DRD3, DRD5 |
2.02694 |
[BP] GO:0051253 |
None
|
APEX1, AR, AURKB, DRD3, ESR1, ESR2, ESRRA, FABP4, HSPA1A, MMP12, PPARA, RELA, RORC, SMAD3, SRC, TERT |
2.02193 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.02193 |
[BP] GO:0006081 |
None
|
AKR1B10, CYP1B1, GLO1, RELA |
2.02193 |
[BP] GO:0048729 |
tissue morphogenesis
|
AR, CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.005 |
[BP] GO:0010959 |
None
|
ADORA1, ADRA2A, CACNA1C, DRD1, DRD2, DRD3, GPR35, KCNH2 |
2.005 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ALPL, APP, AR, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CSNK2A1, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F3, FLT3, GLO1, GPR35, HCAR2, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, MMP2, PIM1, PTPN1, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT |
4.08395 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, APP, AR, AURKB, CA1, CA2, CA4, CA5A, CA5B, CA7, CACNA1C, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MMP2, MMP9, PIM1, PTGES, PTPN1, RELA, SLC6A4, SMAD3, SRC, TERT, TOP2A, TYR, XDH |
3.66196 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRA2A, ALOX5, ALPL, APP, AR, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, F3, FLT3, FUT7, GLO1, GPR35, HCAR2, HSD11B1, HSD17B2, HSD17B3, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP2, PIM1, PTGES, PTPN1, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TYR |
3.43889 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.35728 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, CES1, CES2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, EGFR, FLT3, HSD11B1, HSD17B2, HSD17B3, PTGES, PTPN1 |
3.29174 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA2A, APP, AXL, CA4, DRD1, DRD2, DRD3, DRD5, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, SLC6A2, SLC6A4, TEK |
3.09486 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, CA1, CA2, CA4, CA5A, CA5B, CA6, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD17B3, HSPA1A, IGF1R, INSR, KDR, MAOA, MAP2K1, MAP3K7, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RELA, RORC, SHBG, SMAD3, SRC, TERT, TOP2A, TYR, XDH |
2.88816 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, ADRA2A, CA2, CA4, CA9, EGFR, TEK |
2.78419 |
[CC] GO:0005783 |
None
|
ADORA1, APEX1, APP, CA4, CES1, CES2, CYP19A1, CYP2D6, FLT3, HSD17B3, HSPA1A, KDR, MAP2K1, PTPN1, XDH |
2.75529 |
[CC] GO:0045121 |
membrane raft
|
APP, EGFR, INSR, KDR, SLC6A2, SLC6A4, SRC, TEK |
2.45944 |
[CC] GO:0043226 |
organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, CA1, CA2, CA4, CA5A, CA5B, CA6, CA9, CACNA1C, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, HSD17B3, HSPA1A, IGF1R, INSR, KDR, MAOA, MAP2K1, MAP3K7, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RELA, RORC, SHBG, SMAD3, SRC, TERT, TOP2A, TYR, XDH |
2.451 |
[CC] GO:0098857 |
membrane microdomain
|
APP, EGFR, INSR, KDR, SLC6A2, SLC6A4, SRC, TEK |
2.44085 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRA2A, APP, AXL, DRD1, DRD2, DRD3, DRD5, FLT3, GPR35, IGF1R, INSR, KDR, MET, SLC6A2, SLC6A4, TEK |
2.42292 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRA2A, APP, AXL, CA2, CA4, CA9, CACNA1C, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, F3, FLT3, GPR35, IGF1R, INSR, KCNH2, KDR, MET, SLC6A2, SLC6A4, SRC, TEK |
2.40742 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, EGFR, HSD11B1, HSD17B2, HSD17B3, PTGES |
2.36238 |
[CC] GO:0031253 |
None
|
ADORA1, CA4, CA9, DRD1, DRD2, DRD5, INSR, SRC |
2.28502 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRA2A, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, F3, FLT3, FUT7, GPR35, HCAR2, HSD11B1, HSD17B2, HSD17B3, IGF1R, INSR, KCNH2, KDR, MAOA, MET, PTGES, PTPN1, SLC6A2, SLC6A4, SRC, TEK, TYR |
2.23786 |
[CC] GO:0044422 |
organelle part
|
AKR1B1, ALOX5, AOX1, APEX1, APP, AR, AURKB, CA4, CA5A, CA5B, CA9, CACNA1C, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, FDPS, FLT3, FUT7, HSD11B1, HSD17B2, HSD17B3, HSPA1A, INSR, MAOA, MAP2K1, MAP3K7, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, TYR |
2.10718 |
[CC] GO:0048471 |
perinuclear region of cytoplasm
|
ACHE, AKR1B1, APEX1, APP, CA4, EGFR, HSPA1A, KCNH2, PTGES, SRC, TYR |
2.06798 |
[CC] GO:0009986 |
cell surface
|
ACHE, APP, AXL, CA4, EGFR, F3, KCNH2, MET, SLC6A2, TEK |
2.06377 |
[CC] GO:0098589 |
membrane region
|
APP, EGFR, INSR, KDR, SLC6A2, SLC6A4, SRC, TEK |
2.01169 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, APP, AR, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SMAD3, TYR, XDH |
18.2296 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, GLO1, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, TYR, XDH |
16.2572 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
16.2108 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DUSP3, EGFR, F3, FDPS, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PTGES, PTPN1, SRC, TEK, TERT, TOP2A, TYR, XDH |
12.2992 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, DRD5, ESR1, ESR2, ESRRA, ESRRB, FDPS, GLO1, MAP3K7, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, TERT, TOP2A, TYR, XDH |
11.0821 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.2788 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.1329 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, SMAD3 |
8.81805 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, ESR1, ESR2, ESRRA, ESRRB, FDPS, GLO1, MAP3K7, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTPN1, RORC, SLC6A2, SLC6A4, SMAD3, TERT, TOP2A, TYR, XDH |
8.32876 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, DRD5, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, PPARA, SLC6A4, SRC, TEK, TOP2A |
7.93199 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
7.85089 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, GLO1 |
7.53827 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, HSD11B1, HSD17B1, HSD17B2, HSD17B3, MAOA, TYR, XDH |
7.28175 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, XDH |
7.05367 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, PPARA, RORC, SMAD3, TEK |
6.8243 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KCNH2, KDR, MET, PPARA, RORC, TEK |
6.82428 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.79881 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, TYR |
6.72314 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
6.60039 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2C19, CYP2D6 |
6.37896 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
6.17127 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
6.17127 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.11588 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KCNH2, KDR, MET, PPARA, RORC, TEK |
5.92875 |
[MF] GO:0005496 |
steroid binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, HSD17B1, RORC, SHBG |
5.86151 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, SRC |
5.77056 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA2A, AR, AXL, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KCNH2, KDR, MET, PPARA, RORC, TEK |
5.69284 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP2C19, CYP2D6 |
5.69236 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.69236 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MAP2K1, MET, SRC, TEK |
5.63722 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, SRC |
5.54071 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, APEX1, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, RELA, SLC6A4, SMAD3, SRC |
5.4412 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRA2A, APEX1, EGFR, ESRRB, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, PTPN1, RELA, SLC6A4, SMAD3, SRC |
5.4343 |
[MF] GO:1901338 |
None
|
ADRA2A, DRD1, DRD2, DRD3, DRD5 |
5.33629 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, TYR |
5.17555 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK |
5.12289 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, EGFR, HSD17B1, IGF1R, INSR, SHBG |
4.73653 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3, DRD5 |
4.56873 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, HSD11B1, HSD17B1, HSD17B2, HSD17B3, XDH |
4.53042 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3, DRD5 |
4.428 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, HSD17B1, PTGES, SRC, XDH |
4.36184 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK |
4.15986 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, AOX1, APP, CSNK2A1, DRD2, EGFR, ESR1, ESR2, FLT3, IGF1R, KCNH2, KDR, MAP3K7, MET, MMP9, RELA, SLC6A4, SMAD3, TERT, TOP2A, TYR, XDH |
3.95053 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, ADRA2A, AOX1, APEX1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, DRD5, EGFR, ESR1, ESR2, ESRRA, ESRRB, FDPS, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, NUAK1, PIM1, PPARA, PTPN1, RELA, RORC, SHBG, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
3.93395 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, DRD3, DRD5, SLC6A4 |
3.92953 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK |
3.72992 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KCNH2, KDR, MAP2K1, MAP3K7, MET, NUAK1, PIM1, SRC, TEK, TERT |
3.47227 |
[MF] GO:0019899 |
enzyme binding
|
ADRA2A, APP, AR, AURKB, CDC25B, CYP1A1, CYP1A2, CYP2A6, CYP2C19, DUSP3, EGFR, ESR1, ESR2, ESRRB, F3, HSPA1A, KCNH2, MET, PPARA, PTPN1, RELA, SLC6A4, SMAD3, SRC, TEK, TOP2A |
3.41615 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
3.25643 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.21554 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
3.14931 |
[MF] GO:0008289 |
lipid binding
|
AR, AXL, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD17B1, PPARA, RORC, SHBG |
2.98525 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, DRD1, DRD2, DRD3, DRD5, EGFR, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, TEK |
2.95331 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, AXL, DRD1, DRD2, DRD3, DRD5, EGFR, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, MET, TEK |
2.95331 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD17B1, HSD17B2, HSD17B3 |
2.87985 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.85515 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.85515 |
[MF] GO:0005057 |
signal transducer activity, downstream of receptor
|
EGFR, INSR, KDR, MAP2K1, MAP3K7, SMAD3 |
2.83577 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.54586 |
[MF] GO:0046983 |
protein dimerization activity
|
ACHE, ADORA1, ADRA2A, AOX1, AR, AXL, DRD2, EGFR, FLT3, KCNH2, RELA, SLC6A4, SMAD3, TERT, TOP2A, TYR, XDH |
2.47739 |
[MF] GO:0008392 |
None
|
CYP2A13, CYP2A6, CYP2C19 |
2.4756 |
[MF] GO:0008391 |
None
|
CYP2A13, CYP2A6, CYP2C19 |
2.4756 |
[MF] GO:0005330 |
None
|
SLC6A2, SLC6A4 |
2.4756 |
[MF] GO:0047374 |
None
|
CES1, CES2 |
2.4756 |
[MF] GO:0042803 |
protein homodimerization activity
|
ACHE, ADRA2A, AOX1, DRD2, FLT3, KCNH2, RELA, SLC6A4, SMAD3, TERT, TOP2A, TYR, XDH |
2.40838 |
[MF] GO:0008134 |
transcription factor binding
|
APEX1, AR, ESR1, ESRRB, FLT3, PIM1, PPARA, RELA, SMAD3, SRC, TERT |
2.34546 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.30241 |
[MF] GO:0001588 |
None
|
DRD1, DRD5 |
2.23866 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.23866 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.23866 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.23866 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.23866 |
[MF] GO:0003674 |
molecular_function
|
ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, AKR1B10, ALOX5, ALPL, AOX1, APEX1, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CDC25B, CES1, CES2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, DRD1, DRD2, DRD3, DRD5, DUSP3, EGFR, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FDPS, FLT3, FUT7, GLO1, GPR35, HCAR2, HSD11B1, HSD17B1, HSD17B2, HSD17B3, HSPA1A, IGF1R, INSR, KCNH2, KDR, MAOA, MAP2K1, MAP3K7, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PPARA, PTGES, PTPN1, RELA, RORC, SHBG, SLC6A2, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, TYR, XDH |
2.2265 |
[MF] GO:0047485 |
None
|
CSNK2A1, HSPA1A, MAP2K1, RELA, TERT |
2.21258 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.18319 |
[MF] GO:0016788 |
None
|
ACHE, ADORA1, ALPL, APEX1, CA1, CA2, CDC25B, CES1, CES2, DUSP3, MAP2K1, PTPN1 |
2.08856 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.06377 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.06377 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.06377 |
[MF] GO:1901363 |
heterocyclic compound binding
|
ADORA1, AOX1, APEX1, APP, AR, AURKB, AXL, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2C19, CYP2D6, EGFR, ESR1, ESR2, ESRRA, ESRRB, FDPS, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAP2K1, MAP3K7, MET, MMP12, NUAK1, PIM1, PPARA, PTPN1, RELA, RORC, SLC6A4, SMAD3, SRC, TEK, TERT, TOP2A, XDH |
2.03097 |
[MF] GO:0019900 |
None
|
ADRA2A, AURKB, CDC25B, DUSP3, EGFR, ESR1, PTPN1, RELA, SMAD3, SRC, TOP2A |
2.01463 |